Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

4 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.

Vitamin D supplementation helps reduce atopic dermatitis severity

01 Dec 2018

Increasing serum 25-hydroxyvitamin D (25(OH)D) levels to >20 ng/ml on top of standard therapy may yield reductions in severity of atopic dermatitis, a study has found.

A total of 65 atopic dermatitis patients were randomized to receive either vitamin D3 at 5,000 IU/day (n=33) or placebo (n=32) plus baseline therapy (topical steroid, soap substitute and emollient) for 3 months. Disease severity was assessed according to Hanifin-Rajka criteria and the severity scale (SCORAD).

Analysis included 58 patients. Serum 25(OH)D levels at the end of the intervention were significantly higher in the treated vs placebo group (p<0.001).

At week 12, patients with higher serum levels of 25(OH)D (≥20 ng/ml), regardless of whether they received supplementation, had a lower SCORAD relative to those with lower levels (<20 ng/ml; p<0.001). Furthermore, the majority (n=9; 80 percent) of patients with lower vitamin D levels had moderate–severe atopic dermatitis despite standard treatment.

Increased vitamin D levels (≥20 ng/ml) resulting from supplementation was strongly associated with remission of atopic dermatitis (p=0.03). This association persisted in patients with serum levels of ≥20 and ≥30 ng/ml.

The present data suggest that vitamin D3 be considered as a relevant adjuvant in the treatment of atopic dermatitis, researchers said. The dose administered in the cohort proved to be safe and effective for increasing 25(OH)D to levels of sufficiency in 3 months.

Additional investigation is needed to establish the cost-benefit ratio of measuring serum 25(OH)D in patients with AD, particularly those with poor response to standard treatment or with relapses, researchers added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

4 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.